Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Estracyt

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
1998
Highly Cited
1998
A 20-mer phosphorothioate oligodeoxynucleotide (ODN) directed against human protein kinase C-alpha (CGP 64128A = ISIS 3521) was… Expand
Is this relevant?
1988
1988
Plasma and tumour concentrations of estramustine, estromustine, estradiol and estrone, the major metabolites of estramustine… Expand
Is this relevant?
1987
1987
Eighty‐two patients with invasive malignant melanoma and no distant metastases were prospectively randomized following their… Expand
Is this relevant?
1984
1984
SummaryThe pharmacokinetics of estramustine phosphate (EMP) was studied in five prostatic cancer patients given single i.v. and… Expand
  • figure 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Highly Cited
1983
Highly Cited
1983
A prospective trial from July 1976 to September 1980 by the National Prostatic Cancer Project randomized newly diagnosed… Expand
Is this relevant?
1981
1981
Plasma concentrations of estramustine phosphate and its major metabolites were measured in patients with prostatic carcinoma… Expand
Is this relevant?
1980
1980
Two hundred and twelve patients treated for prostatic cancer grade I or II were investigated for cardiovascular complications… Expand
Is this relevant?
Highly Cited
1977
Highly Cited
1977
Estramustine phosphate (Estracyt) was used in the treatment of 154 patients with carcinoma of the prostate in stage IV. Sixty… Expand
Is this relevant?
1976
1976
Estraumustine phosphate (estradiol, 3-N-[bis(2-chloroethyl)-] carbamate-17beta-dihydrogenphosphate (Estracyt) labeled with 3H in… Expand
Is this relevant?
1971
1971
Sixty-five patients with advanced prostatic carcinoma that had not responded to conventional therapy were treated with Estracyt… Expand
Is this relevant?